14158 Results (Page 542 of 567)
All Market Research Reports
Mexico Genomic Diagnostics Market Analysis
Mexico Genomic Diagnostics Market was valued at $489.75 Mn in 2023 and is predicted to grow at a CAGR of 16.75% from 2023 to 2030, to $1,448.01 Mn by 2030. The key drivers of this industry include increasing demand for personalized medicine, government initiatives, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Vietnam Head and Neck Cancer Therapeutics Market Analysis
The Vietnam Head and Neck Cancer Therapeutics Market was valued at $3.42 Mn in 2023 and is predicted to grow at a CAGR of 14% from 2023 to 2030, to $8.55 Mn by 2030. The key drivers of this industry include rising incidence, aging population, and rising disposable income. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.
Brazil Ear Infection Therapeutics Market Analysis
Brazil Ear Infection Therapeutics Market valued at $295 Mn in 2022, is projected to reach $477 Mn by 2030 with a 6.2% CAGR. The increasing prevalence of ear infections, especially in children, is a major factor contributing to the expansion of the market for therapeutics aimed at treating ear infections. This surge serves as a driving force for substantial research, development efforts, and the introduction of various treatments to tackle this prevalent medical issue. Prominent players in this industry include Pfizer, Novartis, Roche, Johnson & Johnson, Bayer, Merck & Co., AstraZeneca, Sanofi, GlaxoSmithKline, and Takeda Pharmaceutical Company.
Singapore PET Scan Market Analysis
The Singapore PET Scan Market was valued at $2.3 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $3.5 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Singapore PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Egypt Head and Neck Cancer Therapeutics Market Analysis
The Egypt Head and Neck Cancer Therapeutics Market was valued at $7.93 Mn in 2023 and is predicted to grow at a CAGR of 13.73% from 2023 to 2030, to $19.52 Mn by 2030. The key drivers of this industry include government initiatives, the aging population, and advancements in treatment options. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.
Canada Ear Infection Therapeutics Market Analysis
Canada Ear Infection Therapeutics Market valued at $944 Mn in 2022, is projected to reach $1416 Mn by 2030 with a 5.2% CAGR. The rising prevalence of ear infections, particularly in children, is a key driver for the growth of the ear infection therapeutics market, as the increased incidence fosters a demand for effective solutions, propelling research, development, and market availability of treatments to address this widespread medical condition. Key players in this industry include Novartis, AstraZeneca, Cipla, Torrent Pharmaceuticals, Wraser Pharmaceuticals, Glenmark, Sun Pharmaceutical, Candela Healthcare, Torque Pharmaceuticals, and Dr Reddy's Laboratories.
Vietnam PET Scan Market Analysis
The Vietnam PET Scan Market was valued at $9.7 Mn in 2023 and is predicted to grow at a CAGR of 5.63% from 2023 to 2030, to $14.2 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the Vietnam PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Kenya Head and Neck Cancer Therapeutics Market Analysis
The Kenya Head and Neck Cancer Therapeutics Market was valued at $0.85 Mn in 2023 and is predicted to grow at a CAGR of 13.60% from 2023 to 2030, to $2.09 Mn by 2030. The key drivers of this industry include government initiatives, growing awareness, and rising incidence. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.
UAE Ear Infection Therapeutics Market Analysis
UAE Ear Infection Therapeutics Market valued at $59 Mn in 2022, is projected to reach $95 Mn by 2030 with a 6.2% CAGR. The rising incidence of ear infections, particularly among children, significantly drives the growth of the ear infection therapeutics market, acting as a catalyst for extensive research, development, and the availability of treatments to address this widespread medical condition. Notable companies in this sector encompass Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Eli Lilly, Novartis, Teva Pharmaceutical, Mylan, Hikma Pharmaceuticals, and Sun Pharmaceutical.
Egypt PET Scan Market Analysis
The Egypt PET Scan Market was valued at $5.4 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $8.7 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Egypt PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Spain Genomic Diagnostics Market Analysis
Spain Genomic Diagnostics Market was valued at $630.15 Mn in 2023 and is predicted to grow at a CAGR of 15.5% from 2023 to 2030, to $1,727.88 Mn by 2030. The key drivers of this industry include technological advancements, personalized medicine, and government initiatives and funding. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
South Africa Head and Neck Cancer Therapeutics Market Analysis
The South Africa Head and Neck Cancer Therapeutics Market was valued at $30.50 Mn in 2023 and is predicted to grow at a CAGR of 13.50% from 2023 to 2030, to $74.01 Mn by 2030. The key drivers of this industry include the aging population, advancement in treatment, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
Kenya PET Scan Market Analysis
The Kenya PET Scan Market was valued at $1.4 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $2.1 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Kenya PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
UK Genomic Diagnostics Market Analysis
UK Genomic Diagnostics Market was valued at $848.90 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $2,190.26 Mn by 2030. The key drivers of this industry include rising disease incidence, increased government support, and growing public awareness. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
India Head and Neck Cancer Therapeutics Market Analysis
The India Head and Neck Cancer Therapeutics Market was valued at $18.30 Mn in 2023 and is predicted to grow at a CAGR of 12.75% from 2023 to 2030, to $42.39 Mn by 2030. The key drivers of this industry include rising incidence, increasing medical tourism, and advancement in treatment. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
Brazil Compression Therapy Market Analysis
Brazil Compression Therapy Market was valued at $95 Mn in 2022 and is estimated to reach $158 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Sigvaris, Medi, Juzo, Jobst, Bauerfeind, Lympha Press, DJO Global, FLA Orthopedics, Al-Medical, and Eurofarma.
China Genomic Diagnostics Market Analysis
China Genomic Diagnostics Market was valued at $2,624.65 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $8,360.74 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, the aging population, and government support. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Canada Mouth Ulcer Therapeutics Market Analysis
The Canada Mouth Ulcer Therapeutics Market was valued at $121.6 Mn in 2023 and is projected to grow at a CAGR of 3.9% from 2023 to 2023, to $158.9 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such Pfizer, Takeda, GSK, Abbott and Sanofi among other players.
Canada Compression Therapy Market Analysis
Canada Compression Therapy Market was valued at $304 Mn in 2022 and is estimated to reach $470 Mn in 2030, exhibiting a CAGR of 5.6% during the forecast period. The rising prevalence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, serves as a significant growth driver for the compression therapy market. Key players in this industry comprise Bauerfeind, Jobst, Medi, Sigvaris, Juzo, LympheDiv, Gibaud, Varisport, CEP, and McDavid.
India PET Scan Market Analysis
The India PET Scan Market was valued at $35.3 Mn in 2023 and is predicted to grow at a CAGR of 8.4% from 2023 to 2030, to $62 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the India PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, Mindray, and Hitachi, among others.
Indonesia Genomic Diagnostics Market Analysis
Indonesia Genomic Diagnostics Market was valued at $195.90 Mn in 2023 and is predicted to grow at a CAGR of 16.5% from 2023 to 2030, to $570.58 Mn by 2030. The key drivers of this industry include prevalence, technological advancements, and government initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
US Mouth Ulcer Therapeutics Market Analysis
The US Mouth Ulcer Therapeutics Market was valued at $638.4 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $728.3 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as AstraZeneca, Takeda Pharmaceuticals, AbbVie, Bayer Inc, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Pfizer, Inc. among others.
China Compression Therapy Market Analysis
China Compression Therapy Market was valued at $99 Mn in 2022 and is estimated to reach $131 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry encompass entities such as Medi, Sigvaris, Juzo, Bauerfeind, Jobst, Amoena, LymphoCare, Activa Healthcare, Variteks, and Ofa Bamberg.
Japan Genomic Diagnostics Market Analysis
Japan Genomic Diagnostics Market was valued at $2,029.48 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $6,090.96 Mn by 2030. The key drivers of this industry include an aging population, rising healthcare expenditure, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Sysmex Corporation, Fujitsu Laboratories among others.
Saudi Arabia Mouth Ulcer Therapeutics Market Analysis
The Saudi Arabia Mouth Ulcer Therapeutics Market was valued at $25.8 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $37.3 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players Pfizer, Teva Pharmaceuticals, GlaxoSmithKline PLC, Riyadh Pharma, Hikma Pharmaceuticals among others.
